medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2015, Número 616

<< Anterior Siguiente >>

Rev Med Cos Cen 2015; 72 (616)


Abordaje de la hipoglicemia en pacientes no diabéticos en edad pediátrica: revisión sistemática

Salazar SR, Acosta GA, Bogarin SR

Idioma: Español
Referencias bibliográficas: 51
Paginas: 663-675
Archivo PDF: 211.24 Kb.


RESUMEN

La presencia de concentraciones séricas de glucosa por debajo de 40 mg/dl en un recién nacido y por debajo de 45 mg/dl en un adulto, es considerada hipoglicemia. Esta puede tener diferentes causas, desde un ayuno prolongado, enfermedad endocrina, metabólica, intoxicaciones, medicamentos, tumores, etc. La hipoglicemia, es una emergencia médica, que puede llevar a síntomas neurológicos severos, daños irreversibles y hasta la muerte. El realizar un diagnóstico diferencial, un abordaje y tratamiento oportuno son claves para el manejo de un paciente con hipoglicemia.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Achoki R, Opiyo N, English M. Mini-review: Management of Hypoglycemia in Children Aged 0-59 Months. J Trop Pediatr. 2010 Aug; 56(4): 227-234

  2. Adzick NS, Thornton PS, Stanley CA, Kaye RD, Ruchelli E. A multidisciplinary approach to the focal form of congenital hyperinsulinism leads to successful treatment by partial pancreatectomy. J Pediatr Surg. 2004; 39(3): 270-275

  3. Antón I, Amartino H, Bidondo MP et al. Guia para pediatras. Sospecha de errores congénitos del metabolismo. Arch Argent Pediatr 2007;105:262- 270

  4. Arnoux JB, Verkarre V, Saint-Martin C, et al. Congenital hyperinsulinism: Current trends in diagnosis and therapy. Orphanet J Rare Dis. 2011; 6: 63-70

  5. Beltrand J, Caquard JM, Arnoux JB, et al. Glucose metabolism in 105 children and adolescents after pancreatectomy for congenital hyperinsulinism. Diabetes Care. 2012; 35(2): 198-203

  6. Bier DM, Leake RD, Haymond RW, Arnold KJ, Gruenke LD, Sperling MA, et al. Measurement of „true“ glucose production rates in infancy and childhood with 6,6-deuteroglucose. Diabetes. 1977; 26(11): 1016-1023

  7. Blasetti A, Chiuri RM, Tocco AM, et al. The effect on recurrent severe hypoglycemia in children with type 1 diabetes: a meta-analysis. Journal of Child Neurology. 2011; 26: 1383- 1391.

  8. Brown K, Rodgers J, Johnstone H, et al. Abnormal cognitive function in treated congenital hypopituitarism. Archives of Disease in Childhood. 2004; 89: 827-830.

  9. Brunelle F, Negre V, Barth MO, Fekete CN, Czernichow P, Saudubray JM, et al. Pancreatic venous samplings in infants with primary hyperinsulinism. Pediatr Radiol 1989; 19: 100-103

  10. Calabria AC, LI C, Gallagher PR, Stanley CA, De Leon DD. GLP-1 receptor antagonist exendin-(9-39) elevates fasting blood glucose levels in congenital hyperinsulinism owing to inactivating mutations in the ATPsensitive K+ channel. Diabetes. 2012;61(10): 2585-2591

  11. Cambiaso P1, Schiaffini R, Pontrelli G, Carducci C, Ubertini G, Crea F, Cappa M. Nocturnal hypoglycaemia in ACTH and GH deficient children: role of continuous glucose monitoring. Clin Endocrinol (Oxf). 2013 Aug;79(2):232-7. doi: 10.1111/ cen.12123. Epub 2013 May 6.

  12. Cavarzere P1, Biban P, Gaudino R, Perlini S, Sartore L, Chini L, et al. Diagnostic pitfalls in the assessment of congenital hypopituitarism. J Endocrinol Invest. 2014 Aug 1.

  13. Clayton PT, Eaton S, Aynsley- Green A, et al. Hyperinsulinism in short chain L-3 hydroxiacil CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001; 108:457.

  14. De Baulny HO. Management and emergency treatments of neonates with a suspicion of inborn errors of metabolism. Semin neonatol. 2002;7:17-26

  15. Doyle ME, Egan JM. Pharmacological agents that directly modulate insulin secretion. Pharmacol Rev. 2003; 55(1): 105- 131

  16. Fafoula O, Alkhayyat H, Hussain K. Prolonged hyperinsulinemic hypoglycemia in newborns with intrauterine growth retardation. Arch Dis Child Fetal Neonatal. Ed 2006; 91: F467

  17. Flyknka-Gantenbein C. Hypoglycemia in childhood: long term effects. Pediatric endocrinology reviews. 2004; 1(Suppl. 3): 530-536.

  18. Fukumoto H, Seino S, Imura H, et al. Characterization and expression of human HepG2/erythrocyte glucosetransporter gene. Diabetes. 1988; 37:657

  19. Geffner ME. Hypopituitarism in childhood. Cancer Control. 2002 May-Jun;9(3):212-22.

  20. Girard J. Gluconeogenesis in late fetal and early neonatal life. Biol Neonate. 1986; 50:237.

  21. Glaser B, Kesavan P, Heyman M, et al. Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med. 1998; 338:226

  22. Gopal-Kothandapani, Hussain K. Congenital Hyperinsulinism: Role of fluorine-18L-3, 4 hydroxyphenylalaninepositron emission tomography scanning. World J Radiol. 2014 June 28; 6(6): 252-260

  23. Hewitt V, Watts R, Robertson J, Haddow G. Mursing and midwifery management of hypoglycemia in healthy term neonates. Int J Evid Based Healthc. 2005. Aug;3(7):169- 205.

  24. Hu S, Xu Z, Jan J, et al. The treatment effect of Diazoxide on 44 patients with congenital hyperinsulinism. J Pediatr Endocrinol Metab. 2012; 25 (11-12): 1119-1122

  25. Hussain K. Diagnosis and management of hyperinsulinaemic hypoglycemia of infancy. Horm Res. 2008; 69(1): 2-13

  26. Ismail D, Kapoor RR, Smith VV, Ashworth M, Blankenstein O, Pierro A, et al. The heterogeneity of focal forms of congenital hiperinsulinism. J Clin Endocrinol Metab. 2012; 97: E94-E99.

  27. Kang L, Routh VH, Kuzhikandathil EV, et al. Physiological and molecular characteristics of rat hypothalamic ventromedial nucleus glucosensing neurons. Diabetes. 2004; 53:549.

  28. Kazlauskaite R, Maghnie M. Pitfalls in the Diagnosis of Central Adrenal Insufficiency in Children. Endocrine Dev. 2010; 17: 96-107.

  29. Kelberman D, Rizzoti K, Lovell- Badge R, et al. Genetic regulation of pituitary gland development in human and mouse. Endocrine reviews. 2009; 30: 790-829.

  30. Ken K Y Ho. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol. 2007; 157: 695-700

  31. Kühnen P, Marquard J, Ernert A, et al. Long-term Lanreotide treatment in six patients with congenital hyperinsulinism. Horm Res Paediatr. 2012; 78(2): 106-112

  32. Levy PA. Inborn errors of metabolism: part 1 overview. Pediatr Rev 2009;30:131-138

  33. Low LCK. Inborn errors of metabolism: clinical approach and management. HKJM. 1996;2: 274- 281

  34. Matschinsky FM. Regulation of pancreatic bet-cell glucokinase: from basics to therapeutics. Diabetes. 2002; 51(3):S394

  35. Mohnike K, Blankenstein O, Christesen HT, De Lonlay J, Hussain K, Koopmans KP, et al. Proposal for a standardized protocol for 18F-DOPA-PET (PET/TC) in congenital hyperinsulinism. Horm Res 2006; 66: 40-42.

  36. Nehling A. Cerebral energy metabolism, glucose transport and blood flow; changes in maturation and adaptation to hypoglyceamia. Diabetes Metab. 1997; 23:18

  37. Piaggio LA. Congenital Adrenal Hyperplasia: Review from a Surgeon´s Perspective in the Beginning of the Twenty-First Century. Front Pediatr. 2013; 1: 50.

  38. Pierro A, Nah SA, Surgical management of congenital hiperinsulinism of infancy. Semin Pediatr Surg. 2011;20(1): 50-53

  39. Prietsch V, Lindner M, Zschocke J, Nyhan L, Hoffmann GF. Emergency management of inherited metabolic disease. J Inherit Metab Dis.2002; 25:531-546

  40. Rahier J, Guiot Y, Sempoux C. Persistent hyperinsulinemic hypoglycemia of infancy: a heterogeneous syndrome unrelated to nesidioblastosis. Arch Dis Child Fetal Neonatal. Ed. 2000; 82: F108-F112

  41. Raimann E, Cornejo V, Jiménez M. Aproximación al diagnóstico y tratamiento de los errores innatos del metabolismo. En: Errores innatos en el metabolismo del niño. 3ra ed. Chile: Editorial Universitaria: 2003

  42. Rineiro MJ, De Lonlay P, Delzescaux T, Boddaert N, Jaubert F, Bourgeois S, et al. Characterization of Hiperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA. J Nucl Med. 2005; 46:560-566

  43. Rose SR, Lustig RH, Burstein S, Pitukcheewanont P, Broome DC, Burghen GA. Diagnosis of ACTH deficiency: comparison of overnight metyrapone test to either low-dose or high-dose ACTH test. Horm Res. 1999;52:73–79

  44. Savas-Erdeve S, Yilmaz Agladioglu S, Onder A, Peltek Kendirci HN, Bas VN, Saqsak E, Cetinkaya S, Aycan Z. An Uncommon Cause of Hypoglycemia: Insulin Autoinmune Syndrome. Horm Res Paediatr. 2014; 23(7).

  45. Shah P, Demirbilek H, Hussain K. Persistent hyperinsulinaemic hypoglycemia in infancy. Seminars in Pediatric Surgery. 2014; 23:76-82

  46. Sharma A, Yak Ti-Fan T. PA.08 Neonatal Hypoglycaemia-A Quality Improvement Project to Improve Service Delivery Using a RHINO. Arch Dis Child Fetal Neonatal Ed. 2014 Jun;99 Suppl 1:A19. doi: 10.1136/ archdischild-2014-306576.53.

  47. Sperling MA, Ganguli S. Leslie N, Landt K. Fetal-perinatal catecholamine secretion: role in perinatal glucose homeostasis. Am J Physiol. 1984; 247:E69

  48. Stanley CA, Lieu YK, Hsu BY, et al. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med. 1998; 338:1352Geffner ME. Hypopituitarism in childhood. Cancer Control. 2002 May- Jun;9(3):212-22.

  49. Tustison WA, Bowen AJ, Crampton JH. Clinical interpretation of plasma glucose values. Diabetes. 1966; 15(11): 775-777.

  50. World Health Organization . Hypoglycaemia of the Newborn: Review of the Literature in Hypoglycaemia. WHO; Geneva: 1997

  51. Zschocke J, Hoffmann GF. Vademecum Metabolicum. Diagnosis and Treatment of Inborn Errors of Metabolism. 3rd ed. Germany: Milupa Metabolics GmbH & Co; 2011:5-6




2020     |     www.medigraphic.com